Tips and hints for the transition: What adult hepatologists should know when accept teens with a pediatric hepatobiliary disease

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 3, 2014, Pages 277-283

  Guercio Nuzio, Salvatore ^a   Tizzard, Sarah Ann ^b   Vajro, Pietro ^c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULTHOOD; ALAGILLE SYNDROME; AUTOIMMUNE LIVER DISEASE; BILE ACID SYNTHESIS; BILE DUCT ATRESIA; CHOLESTASIS; CRIGLER NAJJAR SYNDROME; EVIDENCE BASED MEDICINE; GLYCOGEN STORAGE DISEASE TYPE 1; HEPATITIS B; HEPATITIS C; HEPATOBILIARY DISEASE; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; METABOLIC DISORDER; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; PATIENT CARE; PHYSICIAN; SHORT SURVEY; TYROSINEMIA; UREA CYCLE DISORDER; WILSON DISEASE; ADOLESCENT; BILE DUCT DISEASES; DISEASE MANAGEMENT; LIVER DISEASES; SURVIVAL; TRANSITION TO ADULT CARE;

ADOLESCENT; BILE DUCT DISEASES; DISEASE MANAGEMENT; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSITION TO ADULT CARE;

EID: 84902553830     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2014.03.012     Document Type: Short Survey

References (23)

1. Samyn M. Optimizing outcomes for pediatric recipients. Liver Transpl 2012, 18:S34-S38.
2. Vajro P., Ferrante L., Lenta S., Mandato C., Persico M. Management of adults with paediatric-onset chronic liver disease: strategic issues for transition care. Dig Liver Dis 2013, 46:295-301.
3. Bijl E.J., Bharwani K.D., Houwen R.H., de Man R.A. The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review. Neth J Med 2013, 71:170-173.
4. Shinkai M., Ohhama Y., Take H., Kitagawa N., Kudo H., Mochizuki K., et al. Long term outcome of children with biliary atresia who were not transplanted after the Kasai operation:>20-year experience at a children's hospital. J Pediatr Gastroenterol Nutr 2009, 48:443-450.
5. Radhakrishnan K.R., Alkhouri N., Worley S., Arrigain S., Hupertz V., Kay M., et al. Autoimmune hepatitis in children-impact of cirrhosis at presentation on natural history and long-term outcome. Dig Liver Dis 2010, 42:724-728.
6. Schramm C., Bubenheim M., Adam R., Karam V., Buckels J., O'Grady J.G., et al. Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl 2010, 16:461-469.
7. Feldstein A.E., Perrault J., El-Youssif M., Lindor K.D., Freese D.K., Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003, 38:210-217.
8. Bortolotti F., Guido M., Bartolacci S., Cadrobbi P., Crivellaro C., Noventa F., et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006, 43:556-562.
9. Iorio R., Giannattasio A., Cirillo F., D' Alessandro L., Vegnente A. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis 2007, 45:943-949.
10. Jara P., Resti M., Hierro L., Giacchino R., Barbera C., Zancan L., et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003, 36:275-280.
11. Venturi C., Bueno J., Castells L., Quintero J., Casas I., Allende H., et al. Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation. Liver Transpl 2011, 17:1474-1480.
12. Feldstein A.E., Charatcharoenwitthaya P., Treeprasertsuk S., Benson J.T., Enders F.B., Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009, 58:1538-1544.
13. Kayler L.K., Rasmussen C.S., Dykstra D.M., Punch J.D., Rudich S.M., Magee J.C., et al. Liver transplantation in children with metabolic disorders in the United States. Am J Transplant 2003, 3:334-339.
14. Beinhardt S., Leiss W., Stättermayer A.F., Graziadei I., Zoller H., Stauber R., et al. Long term outcomes of patients with Wilson's disease in a large Austrian cohort. Clin Gastroenterol Hepatol 2014, 12:683-689.
15. Lykavieris P., Hadchouel M., Chardot C., Bernard O. Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut 2001, 49:431-435.
16. Pawlikowska L., Strautnieks S., Jankowska I., Czubkowski P., Emerick K., Antoniou A., et al. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol 2010, 53:170-178.
17. Gonzales E., Grosse B., Cassio D., Davit-Spraul A., Fabre M., Jacquemin E. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2. J Hepatol 2012, 57:695-698.
18. Lodoso Torrecilla B., Palomo Atance E., Camarena Grande C., Díaz Fernández M.C., Hierro Llanillo L., De la Vega Bueno A., et al. Crigler-Najjar syndrome: diagnosis and treatment. An Pediatr (Barc) 2006, 65:73-78.
19. Perretti A., Crispino G., Marcantonio L., Lenta S., Caropreso M., Vajro P. Clinical utility of electrophysiological evaluation in Crigler-Najjar syndrome. Neuropediatrics 2007, 38:173-178.
20. Webb N., Harden P., Lewis C., Tizzard S., Walsh G., Wray J., et al. Building consensus on transition of transplant patients from paediatric to adult healthcare. Arch Dis Child 2010, 95:606-611.
21. Busuttil R.W., Farmer D.G., Yersiz H., Hiatt J.R., McDiarmid S.V., Goldstein L.I., et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. Ann Surg 2005, 241:905-916.
22. Bucuvalas J.C., Alonso E., Magee J.C., Talwalkar J., Hanto D., Doo E. Improving long-term outcomes after liver transplantation in children. Am J Transplant 2008, 8:2506-2513.
23. Rothbaum Perito E., Lau A., Rhee S., Roberts J.P., Rosenthal P. Post-transplant metabolic syndrome in children and adolescents after liver transplant: a systematic review. Liver Transpl 2012, 18:1009-1028.